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THE EFFECTS OF SUXAMETHONIUM AND
PANCURONIUM ON THE HAEMODYNAMIC RESPONSE
TO ENDOTRACHEAL INTUBATION
Pages with reference to book, From 51 To 54 
Fauzia A. Khan, Rehana S. Kamal ( Department of Anaesthesiology, The Aga Khan University Hospital and Medical
college, Karachi. ) 
ABSTRACT 
The pharmacological effects of suxamethonium and pancuronium on the cardiovascular system may
vary and therefore alter the haemodynamic response to intubation. The arterial blood pressure, the heart
rate and the rate pressure product were measured as parameters of haemodynamic change in forty adult
ASA. I and II patients undergoing laryngoscopy and endotracheal intubation in a randomised controlled
study. The patients were induced with either thiopentone/suxamethonium (Group A) or
thiopentone/pancuronium (Group B). There was no significant difference between the groups on
comparison of systolic and diastolic blood pressure changes. Pancuronium, however, caused a
significantly higher rise in the heart rate after endotracheal intubation compared to suxamethonium. In
both groups the maximum rate pressure product occurred one minute after intubation, rising by 56% in
the suxamethonium group and 64% in the pancuronium group compared to control values. In
conclusion, there were significant and statistically similar increases in systolic and diastolic blood
pressures and rate pressure product following intubation in both groups with values significantly above
baseline until three minutes post intubation but the increase in heart rate in group A was significantly
less than that in group B (JPMA 41: 51, 1991).
INTRODUCTION 
In normotensive adults the usual response to laryngoscopy and endotracheal intubation is hypertension
and tachycardia which has been well documented in several studies1-3. This response was shown to be
sympathetically mediated in anaesthetized cats and was due to the stimulation of epipharynx and
laryngopharynx4. More recent studies have pointed out that in normotensive patients there is a
moderate increase in the plasma catecholamine levels following laryngoscopy with little or no
contribution from intubation5. Mostofthese studies have been done using thiopentone/suxame-thonium
induction. It is a generally held view that compared to a rapid sequence induction with thiopentone and
suxamethonium, thiopentone and pancuronium results in a greaser degree of haemodynamic stability.
The pharmacological properties of a muscle relaxant may seem to be of less significance than the
stimulus of laryngotracheal stimulation, but may be contributory to the overall haemodynamic response
and this may be of importance in patients who have underlying ischemic heart disease where the
increase in myocardial oxygen demand may lead to myocardial ischemia. The objective of our study
was therefore to focus on the choice of a muscle relaxant for intubation and to find out whether using
thiopentone/pancuronium induction had any advantage or disadvantage over
thiopentone/suxamethonium induction as far as the haemodynamic response was concerned. We used
the changes in the systolic arterial pressure, the diastolic arterial pressure, heart rate and the rate
pressure product as our parameters of haemodynamic change.
METHODS 
Forty adult ASA I and II patients of either sex aged between 18-60 years undergoing elective surgery
requiring endotracheal intubation were allocated randomly to two groups A and B of twenty each.
Patients with a previous history of hypertension were excluded. It was not possible to use a blind
technique due to the differences in the onset tilne of the neuromuscular blockade between the two
groups. The patients were premedicated with oral diazepam 0.15 mg/kg given two hours before
surgery. On arrival in the operating room an 18-gauge I/V cannula was placed on the contralateral arm.
EGG (CM5 lead) was displayed continuously and oxygen saturation was monitored throughout the
procedure using the finger probe of Ohmeda Biox 3700 Pulse Oximeter. The control readings of
systolic, diastolic and mean blood pressure and heart rate were taken after a stabilization period of five
minutes. All the patients were preoxygenated for three minutes. Group A patients were then
anaesthetized with thiopentone 4 mg/kg over 15 second followed by suxamethonium 1.5 mg/kg over 15
seconds. The patients lungs were ventilated with 33% oxygen and 66% nitrous oxide with a face mask
and a Magill’s circuit. The Capnograph (Data) sampling catheter was placed under the mask to monitor
the end expired carbon dioxide tensions which were kept at 5-5.5%. Intubation was performed exactly
90 seconds after the suxamethonium injection using a standard Mackintosh blade laryngoscope. Male
patients were intubated with a 9.0 mm and female patients with an 8.0 mm cuffed Magill’s red rubber
tube. Group B patients received thiopentone 4mg/kg over 15 seconds followed by pancuronium 0.1
mg/kg over 15 seconds. They were ventilated according to the same protocol as group A patients and
were intubated three minutes after the pancuronium injection. All intubatipns were accomplished
within 30 seconds by the same anaesthetist. Subsequently, both the groups were ventilated undisturbed
for a further 7 minutes maintaining an end tidal carbon-dioxide concentration at 5-5.5%. The group A
patients were given pancuronium after the action of suxamethonium had worn off and this time was
noted. Monitoring of heart rate and blood pressure was continued and recorded every minute after
intubation and the rate pressure product calculated. Statistical analysis was by student’s t test and a
value of less than 0.05 was considered significant.
RESULTS 
There was no significant difference between the groups in respect of age, weight or the distribution of
males and females, and the control values of systolic arterial pressure, diastolic arterial pressure, heart
rate and the rate pressure product (Table I).
Table II gives the changes in the haemodynamic parameters in the two groups during induction of
anaesthesia and upto three minutes following intubation. Systolic Arterial Pressure: The changes in
systolic arterial pressure in the two groups are shown in Table II. The systolic arterial pressure in both
groups rose significantly above the control values at one minute after intubation and remained
significantly elevated until three minutes after intubation. No statistical difference was observed
between the groups. Diastolic Arterial Pressure: The changes in the diastolic arterial pressure mirrored
the changes in the systolic pressure. The maximum rise occurred at 1 minute post-mtubation. Heart
Rate: In both groups the heart rate increased significantly after thiopentone/relaxant injection compared
to the control. The increase was 17.6% in group A and 20.7% in group B. The heart rate in both groups
rose further after laryngoscopy and intubation, and remained significantly elevated compared to control
until 3 minutes post-intubation (Table II). On comparison between the two groups the different was not
statistically significant after thiopentone/relaxant injection one minute after intubation but became
significant at 2 minutes and 3 minutes after intubation when the heart rate in group A patients
(thiopentone /suxamethonium) remained significantly lower than group B. None of the patients in
group A showed bradycardia i.e., heart rate less than 60 beats per minute at any time. Rate Pressure
Product: The maximum increase in the rate pressure product compared to the control values was found
at one minute after intubation in both groups. In group A (Suxamethonium group) the rate pressure
product rose to a mean of 18,117 compared to a control value of 11,572, this rise being statistically
significant. In group B (pancuronium group) the rate pressure product rose to 18,277 compared to the
control value of 11,028. This rise was again statistically significant. The magnitude of rise from the
control was more in the pancuronium group (mean rise of + 7, 199) compared to the suxamethonium
group (mean rise of +6, 545). This difference between the two groups was not statistically significant.
(Table II). The values of rate pressure product gradually decreased over the next three minutes but
remained significantly elevated compared to the control. The absolute values in group A were clinically
lower than those of group B. None of patients in group A showed a rise in the rate pressure product
compared to the previous readings after being given pancuronium injection.
Figure 1 shows the percentage increase in the rate pressure product compared to the control values in
both the groups at 1,2,3 and 4 minutes after intubation.
Figure 2 compares the maximum rate pressure product reached in different patients in the two groups
(Figure 2).
DISCUSSION 
The pharmacological properties of induction agents and other drugs used during routine general
anaesthesia have been shown to alter the  cardiovascular responses to intubation. A bolus dose of
thiopentone decreases the arterial  pressure, stroke volume and cardiac output. It also causes a decrease
in the peripheral  venous tone6. Its effect on the heart rate is variable, a rise or a no chasnge have both
been reorted in different studies6,7. It has also been shown that catecholamine response to  intubation
differs with muscle relaxants8,11. Both suxamethonium and pancuronium are widely  used to provide
muscle relaxation for endotraccheal intubation especially in developing  countries where other newer
alternatives for muscle relaxation may not be available. The  pharmacological effects of the two drugs
on the cardiovascular system varies. Suxamethonium  may causes bradycardia and a fall in blood
pressure due to vagal stimulation12. Pancuronium bromide on the other hand causes a moderate rise in
the pulse rate and arterial blood pressure of 10-20% and an increasein cardiac output. These changes
donot occur in atropinized individuals therefore, indicating that the mechanism is due to the vagolytic
effect of the drug13. The effect of intubation may also be potentiated by pancuronium due to the
enhancement of circulating catecholamines by inhibition of noradrenaline uptake12. These
pharmacological effects of the durgs though known but their combination of effect with thiopentone
bolus and the differences in their effect on the haemodynamic response has not been quantified before
in a clinical trial. The blood pressure changes in both groups were similar and did not show any
statistical difference on comparison. The only statistical difference observed between the two groups
was their effect on the heart rate which remained significantly lower in the thiopentone /suxame-
thonium group at 2 and 3 minutes after intubation. None of the patients in either group had bradycardia.
This probably reflects that the sympathetic stimulation associated with laryngoscopy masked the
vagotonic effect of suxamethonium but pharmacological effect of pancuronium could have been
additive. This also accounted for a higher rate pressure product in group B. The rise in the heart rate
compared to control that was observed in both groups after thiopentone/relaxant injection, has been
reported after thiopentone in other studies7 and is probably compensatory. The rate pressure product
was measured because it is said to reflect the myocardial oxygen consumption13 and is a guide to the
development of myocardial ischemia14. The level of rate pressure product where myocardial ischemia
occurs varies in different patients but the levels in excess of 22,000 are said to be more commonly
associated with angina and myocardial ischemia in patient with underlying ischemic heart disease15,16.
In our study the rate pressure product rose in both groups following laryngoscopy and intubation with a
maximum increase at one minute after intubation. In group A the maximum rise was to 18,117 (control
11,572). This rise was statistically significant and is comparable to figures quoted by Davies17 with the
same technique. It gradually decreased over the next three minutes but did not fall to the baseline. In
the pancuronium group (Group B) the maximum rise was again observed at one minute post-intubation,
with a rate pressure product of 18,277 (control 11,082) which was statistically significant. This was
comparable to the values obtained with thiopentone and pancuronium by Boralessa18. The value again
decreased over the next three minutes but did not come back to the baseline. Three patients in each
group had a rate pressure product above 22,000. None of these patients showed any ST segment
changes on the ECG monitor, this was because the patients chosen for study were ASA I and II with no
underlying cardiac problems. Further readings of all haemodynamic parameters were taken but were
not included in the post intubation response because most of the patients required a nondepolarising
muscle relaxant in the suxamethonium group. It has been pointed out by some authors that a rise in the
heart rate is more detrimental than the rise in blood pressure. This rise in the heart rate leads to
increased myocardial oxygen supply, where as rise in systolic arterial pressure although increases the
oxygen demand but also increases the mean and diastolic blood pressure thereby increasing the
perfusion pressure19. Keeping this in mind the thiopentone/suxamethonium combination for induction
may be a better choice than thiopentone /pancuronium induction as far as the stress on the myocardium
is concerned. Another factor which may account for a difference between the results in two groups is
the variable interval from the injection of thiopentone to intubation due to the difference in the time of
onset of muscle relaxation of the two drugs. Intubation in group A was performed 90 seconds after
thiopentone/suxamethomum injections, and in group B 180 seconds after thiopentone/pancuronium
injection. This could have resulted in a slightly lighter level of anaesthesia in group B patients and
could contribute to the overall haemodynamic response. In conclusion both the techniques caused a
significant rise in the systolic and diastolic arterial pressures, heart rate and rate pressure product
following intubation. There was no statistical difference between the two groups except in the heart rate
which was significantly higher in the pancuronium group and accounted for a higher rate pressure
product in that group. Therefore as far as the haemodynamic response is concerned a thiopentone/suxa-
methonium combination may be preferable to thiopentone/pancuronium.
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